Shalini Sharp, CFO & Executive Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 24,000 shares at $70.06 ($1.7M) on 2016-11-09, disclosed to the SEC on 2016-11-10.
Open-market sale of $1.7M RARE by CFO & Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.06 | 13,600 | $953K | 55.8% |
| 2 | $71.68 | 3,895 | $279K | 16.3% |
| 3 | $72.81 | 3,205 | $233K | 13.7% |
| 4 | $73.65 | 2,600 | $191K | 11.2% |
| 5 | $74.34 | 700 | $52K | 3.0% |
| Total | $71.20 avg | 24,000 |
| $1.7M |
| 100% |
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |